Showing 21 - 40 results of 163 for search '"biopharmaceutical"', query time: 0.07s Refine Results
  1. 21
  2. 22
  3. 23

    Application of the Box–Behnken Design in the Development of Amorphous PVP K30–Phosphatidylcholine Dispersions for the Co-Delivery of Curcumin and Hesperetin Prepared by Hot-Melt Ex... by Kamil Wdowiak, Lidia Tajber, Andrzej Miklaszewski, Judyta Cielecka-Piontek

    Published 2024-12-01
    “…<b>Conclusions:</b> The findings suggest that amorphous PVP K30–phosphatidylcholine dispersions have the potential to improve the biopharmaceutical properties of curcumin and hesperetin.…”
    Get full text
    Article
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29

    Evaluation of Recombinant Antibody Production Efficiency in CHO Cells with Sleeping Beauty Transposon Vector System by Pelin Kolçak Yaşlı, Seda Kulabaş, Evren Doruk Engin

    Published 2024-09-01
    “…Chinese hamster ovary (CHO) mammalian cell lines are widely used as cell platforms in biopharmaceutical productions. Different transfection systems are employed for the integration of the target gene cassette into the cell genome and have limitations, such as (i) the integration region in the genome, (ii) the size of the target cassette, and (iii) long selection periods for stable expression. …”
    Get full text
    Article
  10. 30

    Sulfate-Reducing Bacteria: Biofilm Formation and Corrosive Activity in Endodontic Files by Fabiano Luiz Heggendorn, Aline Guerra Manssour Fraga, Dennis de Carvalho Ferreira, Lucio Souza Gonçalves, Viviane de Oliveira Freitas Lione, Márcia Teresa Soares Lutterbach

    Published 2018-01-01
    “…The biocorrosive potential of these bacteria will be an important component of a biopharmaceutical under development called BACCOR. Afterwards, four used endodontic files (UEFs) were separately inoculated into a specific culture media for 445 days at 30°C in an incubator. …”
    Get full text
    Article
  11. 31

    Antibodies to watch in 2024 by Silvia Crescioli, Hélène Kaplon, Alicia Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M. Reichert

    Published 2024-12-01
    “…Overall, our data suggest that antibody therapeutic development efforts by the biopharmaceutical industry are robust and increasingly successful.…”
    Get full text
    Article
  12. 32
  13. 33

    Plant Resin Delivery by Nanovectors as an Emerging Approach to Boost Solubility, Permeability and Bioavailability by Eleonora Truzzi, Giulia Vanti, Lucia Grifoni, Eleonora Maretti, Eliana Leo, Anna Rita Bilia

    Published 2025-01-01
    “…Therefore, nanovectors including vesicles, solid lipid nanoparticles, micelles, nanoemulsions, microemulsions and mesoporic nanoparticles have been investigated to optimize the biopharmaceutical properties after topical or oral administration of resins or fractions from them, including essential oils or single constituents. …”
    Get full text
    Article
  14. 34
  15. 35
  16. 36
  17. 37

    Total Organic Carbon Analysis of Residual Contaminants in Bioreactor Equipment: A Cleaning Verification Study using Surface Swabbing by Ciara E. Fitzpatrick, James J. Roche

    Published 2024-12-01
    “…Contamination is a major issue in the biopharmaceutical industry. Bioreactors must be meticulously cleaned to remove residual impurities and avoid cross-contamination. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40

    Application of natural β-glucans as biocompatible functional nanomaterials by Xiaojie Li, Peter Chi Keung Cheung

    Published 2019-12-01
    “…Keywords: β-Glucans, Biocompatibility, Biopharmaceuticals, Nanohybrids…”
    Get full text
    Article